Table TDI-4. Characteristics of new clients entering treatment: demographics and primary drug at treatment in 2006 or most recent year available [see all tables in this series...]

Part (ii) Primary drug type used (percent of new clients using) and of those, the percent injecting it

Country		Opioids	% inj	Cocaine	% inj	Amphe tamines	% inj	Ecstasy	Halluci nogens	% inj	Cannabis	Others		% Injecting main drug
Bulgaria		93.2	74.8			2.7					3.7			69.2
Czech Republic		16.6	79.7	0.1		61.4	74.9	0.2	0.1		18.3	0.9		60.5
Denmark		15.4	16.6	10.1	1.7	14.9		2.0			50.5	6.2		2.9
Germany	(1)	22.4	39.7	7.7	11.7		0.8		0.2	0.6	56.1	1.8		8.1
Ireland		36.0	27.4	13.4	1.1	7.3		2.6	0.0		31.0	0.2		11.5
Greece		83.3	40.7	3.3	6.5			0.3	0.1		11.6	0.3		36.2
Spain	(2)	16.3	14.3	63.4	5.2	1.1	3.9	0.7	0.1		16.3	0.3		5.6
France		30.4	14.6	4.7	9.1	0.3	4.3	0.6	0.2		62.0	0.6		4.7
Italy		49.6	51.6	28.5	10.0	0.2	11.3	0.5	0.1		18.4	2.2		28.6
Cyprus		35.7	75.0	17.9	2.5			3.1			43.3			27.2
Latvia	(3)	39.6		38.0		24.5		0.4	1.3		11.1	4.5		53.5
Lithuania	(4)	76.5	74.9	0.3	0.0				0.3	0.0	1.5	16.4		92.8
Luxembourg	(5)	79.8	72.1	14.6	56.4	0.5		1.9	0.3		1.9	0.5		65.8
Hungary		7.4	66.0	1.1	7.8	5.3	17.4	2.2	0.5		54.1	8.5		6.2
Malta		64.0	64.0	12.0	23.0			5.0	0.0		19.0			44.6
Netherlands		10.5	8.3	31.6	0.2	7.5	0.6	1.2	1.8		43.3	0.9		0.9
Austria	(6)	50.8	33.5	7.3	11.4	2.5		1.0	0.2		34.8	0.1		18.3
Poland	(7)	19.8		1.2		11.9			0.8		4.4	61.9
Portugal	(8)	76.5		8.5		0.2		0.3	0.4		10.8	2.9
Romania		71.2	97.5	0.2		0.5	50.0	0.3			5.6	6.5		70.0
Slovenia	(9)	77.6	64.2	1.1	16.7	0.2	0.0	1.0	0.0		19.6	0.5		50.1
Slovakia		27.6	79.4	1.7	8.3	32.2	37.5	0.4	0.1		26.9			33.6
Finland		25.0	71.0			23.0	71.0				41.0	1.0		35.0
Sweden		19.1	26.7	3.3		26.7	47.8	0.4	0.7		30.4	3.4		17.9
United Kingdom	(10)	49.7	35.5	15.8	3.0	3.9	17.7	1.0	0.2	8.6	24.8	1.5		18.4
Turkey		28.56	42.6	3.5				4.21			50.84	0.8		12.2

Notes:

 Data were not available for: Belgium, Estonia, Norway. 

 When proportion of clients by main drug is 0, ‘% of injectors’ is blank. If no data is available, the cell is left blank. 

 (1) Data on amphetamines include amphetamines and ecstasy. 

 (2) Last data available refer to 2005. 

 (3) No data on injecting rates for 2005. 

 (4) Amphetamines rates refer to stimulants in general. 

 (5) Data on first treatments were not reported for 2006 as the figures were too small. Data refer to all treatments. Values based on total sample size = 193. 

 (6) In the case of Austria, up to 2005 data only refer to clients in substitution treatment, using opioids as primary drug. Since 2006 new data collection has been conducted. 

 (7) Last data available refer to 2005. Amphetamines refer to amphetamines+ ecstasy. 

 (8) No data on injection available for 2006. Cocaine includes cocaine + freebase. 

 (9) Last data available refer to 2004. It includes data for outpatient clients and clients treated in prison. Data for outpatient clients was validated, however data collection for prison clients was still in the process of development, thus figures are underestimated.With effect from next year the process of data validation for prison clients will be implemented. 

 (10) Data relate to the period from 1 April 2005 to 31 March 2006 for the UK. 

 See also ‘General notes for interpreting data’ on the Explanatory notes and help page. 

Sources:

 Reitox national reports 2007 — Standard table 3. See Table TDI-1 for details on sources. 

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)